Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 4
1992 1
1993 2
1994 3
1996 5
1997 3
1998 4
1999 6
2000 3
2001 3
2002 1
2003 6
2004 3
2005 5
2006 6
2007 1
2008 10
2009 4
2010 8
2011 8
2012 11
2013 5
2014 8
2015 11
2016 12
2017 17
2018 22
2019 22
2020 28
2021 19
2022 21
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Garcia-Olmo D, Gilaberte I, Binek M, D Hoore AJL, Lindner D, Selvaggi F, Spinelli A, Panés J. Garcia-Olmo D, et al. Dis Colon Rectum. 2022 May 1;65(5):713-720. doi: 10.1097/DCR.0000000000002325. Dis Colon Rectum. 2022. PMID: 34890373 Free PMC article. Clinical Trial.
XVI SECAL Congress.
García-Olmo DC. García-Olmo DC. Lab Anim. 2022 Apr;56(2):204-205. doi: 10.1177/00236772221080391. Lab Anim. 2022. PMID: 35511488 No abstract available.
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Panés J, et al. Among authors: garcia olmo d. Lancet. 2016 Sep 24;388(10051):1281-90. doi: 10.1016/S0140-6736(16)31203-X. Epub 2016 Jul 29. Lancet. 2016. PMID: 27477896 Clinical Trial.
Living medicines: Training before handling.
García-Arranz M, Garcia-Olmo D. García-Arranz M, et al. Among authors: garcia olmo d. Cytotherapy. 2022 Jul;24(7):673. doi: 10.1016/j.jcyt.2021.12.007. Epub 2022 Feb 19. Cytotherapy. 2022. PMID: 35193827 No abstract available.
Liquid biopsy in cancer.
Salinas Sánchez AS, Martinez Sanchis C, Gimenez Bachs JM, García Olmo DC. Salinas Sánchez AS, et al. Among authors: garcia olmo dc. Actas Urol Esp. 2016 Jan-Feb;40(1):1-2. doi: 10.1016/j.acuro.2015.06.008. Epub 2015 Aug 18. Actas Urol Esp. 2016. PMID: 26296278 English, Spanish. No abstract available.
Circulating DNA and Survival in Solid Tumors.
Ocaña A, Díez-González L, García-Olmo DC, Templeton AJ, Vera-Badillo F, José Escribano M, Serrano-Heras G, Corrales-Sánchez V, Seruga B, Andrés-Pretel F, Pandiella A, Amir E. Ocaña A, et al. Among authors: garcia olmo dc. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):399-406. doi: 10.1158/1055-9965.EPI-15-0893. Epub 2015 Nov 24. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26604269 Review.
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.
Fernández-Santos ME, Garcia-Arranz M, Andreu EJ, García-Hernández AM, López-Parra M, Villarón E, Sepúlveda P, Fernández-Avilés F, García-Olmo D, Prosper F, Sánchez-Guijo F, Moraleda JM, Zapata AG. Fernández-Santos ME, et al. Among authors: garcia olmo d. Front Immunol. 2022 Jun 9;13:918565. doi: 10.3389/fimmu.2022.918565. eCollection 2022. Front Immunol. 2022. PMID: 35812460 Free PMC article. Review.
256 results